Speaker illustration

Doctor Jeffrey Michel

Baylor Scott and White Health, Austin (United States of America)

Time to event analysis in patients managed on rivaroxaban while taking concurrent interacting medications (CIM)

Event: ESC Congress 2018

Topic: Anticoagulants

Session: Antiplatelet and anticoagulant drugs

Thumbnail

Increased bleeding events in patients co-administered rivaroxaban and either cyp3A4 or p-gp inhibitors

Event: ESC CONGRESS 2017

Topic: Pharmacology

Session: How to make oral anticoagulation safe

Thumbnail

ESC 365 is supported by

logo Novo Nordisk